CRISPR/Cas mediated epigenome editing for cancer therapy.

Abstract:

:The understanding of the relationship between epigenetic alterations, their effects on gene expression and the knowledge that these epigenetic alterations are reversible, have opened up new therapeutic pathways for treating various diseases, including cancer. This has led the research for a better understanding of the mechanism and pathways of carcinogenesis and provided the opportunity to develop the therapeutic approaches by targeting such pathways. Epi-drugs, DNA methyl transferase (DNMT) inhibitors and histone deacetylase (HDAC) inhibitors are the best examples of epigenetic therapies with clinical applicability. Moreover, precise genome editing technologies such as CRISPR/Cas has proven their efficacy in epigenome editing, including the alteration of epigenetic markers, such as DNA methylation or histone modification. The main disadvantage with DNA gene editing technologies is off-target DNA sequence alteration, which is not an issue with epigenetic editing. It is known that cancer is linked with epigenetic alteration, and thus CRISPR/Cas system shows potential for cancer therapy via epigenome editing. This review outlines the epigenetic therapeutic approach for cancer therapy using CRISPR/Cas, from the basic understanding of cancer epigenetics to potential applications of CRISPR/Cas in treating cancer.

journal_name

Semin Cancer Biol

authors

Ansari I,Chaturvedi A,Chitkara D,Singh S

doi

10.1016/j.semcancer.2020.12.018

subject

Has Abstract

pub_date

2021-01-06 00:00:00

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(20)30278-9

pub_type

杂志文章
  • Current and upcoming mitochondrial targets for cancer therapy.

    abstract::Mitochondria are essential intracellular organelles that regulate energy metabolism, cell death, and signaling pathways that are important for cell proliferation and differentiation. Therefore, mitochondria are fundamentally implicated in cancer biology, including initiation, growth, metastasis, relapse, and acquired ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.06.006

    authors: Kim HK,Noh YH,Nilius B,Ko KS,Rhee BD,Kim N,Han J

    更新日期:2017-12-01 00:00:00

  • Mitochondrial ribosomes in cancer.

    abstract::Mitochondria play fundamental roles in the regulation of life and death of eukaryotic cells. They mediate aerobic energy conversion through the oxidative phosphorylation (OXPHOS) system, and harbor and control the intrinsic pathway of apoptosis. As a descendant of a bacterial endosymbiont, mitochondria retain a vestig...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.04.004

    authors: Kim HJ,Maiti P,Barrientos A

    更新日期:2017-12-01 00:00:00

  • The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives.

    abstract::The escalating epidemic of overweight and obesity is currently recognized as one of the most significant health and economic concern worldwide. At the present time, over 1.9 billion adults and more than 600 million people can be, respectively, classified as overweight or obese, and numbers will continue to increase in...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.09.001

    authors: Barone I,Giordano C,Bonofiglio D,Andò S,Catalano S

    更新日期:2020-02-01 00:00:00

  • Antisense oligonucleotides.

    abstract::Growing evidence indicates that antisense oligodeoxynucleotides can specifically inhibit gene expression thereby providing an essential tool for understanding gene function and the potential to affect abnormal cell proliferation. Because oncogene activation is intimately involved in tumour initiation and progression, ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Calabretta B,Skorski T,Zon G

    更新日期:1992-12-01 00:00:00

  • A molecular genetic model of human bladder carcinogenesis.

    abstract::Human bladder carcinogenesis stands as a paradigm for research on the molecular genetic mechanisms of chemical carcinogenesis. The pathogenesis of bladder cancer is multistage with a typical onset later in life. Epidemiological studies associate occupational exposure to aromatic amines with increased bladder cancer ri...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Reznikoff CA,Kao C,Messing EM,Newton M,Swaminathan S

    更新日期:1993-06-01 00:00:00

  • Laminin isoforms in tumor invasion, angiogenesis and metastasis.

    abstract::Laminins are a growing family of alphabetagamma heterotrimeric proteins, commonly found in basement membranes (BMs). These large molecules promote cell adhesion and migration via integrins and other cell-surface receptors. Over 12 laminin isoforms are presently known. The various isoforms have a cell- and tissue-speci...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/S1044-579X(02)00023-8

    authors: Patarroyo M,Tryggvason K,Virtanen I

    更新日期:2002-06-01 00:00:00

  • Proof for EBV's sustaining role in Burkitt's lymphomas.

    abstract::We have found that not all Epstein-Barr viral (EBV) plasmids are duplicated each cell cycle. This inefficiency is intrinsic to EBV's mechanism of DNA synthesis in latently infected cells and necessarily leads to a loss of EBV plasmids from proliferating cells. If EBV provides its host cells advantages that allow those...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2009.07.006

    authors: Vereide D,Sugden B

    更新日期:2009-12-01 00:00:00

  • Novel functions of interferon-induced proteins.

    abstract::Interferons are important cytokines which regulate antiviral, cell growth, immune modulatory and anti-tumor functions. These pleiotropic effects of interferons are brought about by a large number of cellular proteins, the interferon-inducible proteins. Investigation of the biochemical and cellular activities of some o...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0312

    authors: Sen GC

    更新日期:2000-04-01 00:00:00

  • Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas.

    abstract::The concept of reverse immune surveillance, first conceived over 12 years ago, described the relationship that existed between germinal center-derived B cell lymphoma cells and the host immune system in SjL/J mice. According to reverse immune surveillance, recognition of tumor cell antigens and a response by the host ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0330

    authors: Ponzio NM,Thorbecke GJ

    更新日期:2000-10-01 00:00:00

  • Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.

    abstract::Epigenetic alterations of the genome such as DNA promoter methylation and chromatin remodeling play an important role in tumorigenesis. Recent findings indicate epigenetic modifications as key factors in breast carcinogenesis. These modifications are quite appealing as targets for preventative care and therapeutics be...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2009.02.007

    authors: Dworkin AM,Huang TH,Toland AE

    更新日期:2009-06-01 00:00:00

  • Nanomedicine in treatment of breast cancer - A challenge to conventional therapy.

    abstract::Amongst the various types of cancer, breast cancer is a highly heterogeneous disease and known as the leading cause of death among women globally. The extensive interdisciplinary investigation in nanotechnology and cancer biomedical research has been evolved over the years for its effective treatment. However, the adv...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.12.016

    authors: Afzal M,Ameeduzzafar,Alharbi KS,Alruwaili NK,Al-Abassi FA,Al-Malki AAL,Kazmi I,Kumar V,Kamal MA,Nadeem MS,Aslam M,Anwar F

    更新日期:2019-12-20 00:00:00

  • Structure and activities of the ski oncogene.

    abstract::The ski oncogene is the transforming gene, v-ski, of the defective SKV avian carcinoma viruses. V-ski transformation causes increased proliferation of embryo fibroblasts and also induces a number of genes characteristic of the muscle lineage. In natural SKV isolates the 49 kDa v-ski polypeptide is expressed as a fusio...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Colmenares C,Stavnezer E

    更新日期:1990-12-01 00:00:00

  • The molecular basis of targeting protein kinases in cancer therapeutics.

    abstract::In this paper, we provide an overview of targeted anticancer therapies with small molecule kinase inhibitors. First, we discuss why a single constitutively active kinase emanating from a variety of aberrant genetic alterations is capable of transforming a normal cell, leading it to acquire the hallmarks of a cancer ce...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2013.04.001

    authors: Tsai CJ,Nussinov R

    更新日期:2013-08-01 00:00:00

  • Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease.

    abstract::Small cell lung cancer (SCLC) is a particular subtype of lung cancer with high mortality. Recent advances in understanding SCLC genomics and breakthroughs of immunotherapy have substantially expanded existing knowledge and treatment modalities. However, challenges associated with SCLC remain enigmatic and elusive. Mos...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.11.006

    authors: Khan P,Siddiqui JA,Maurya SK,Lakshmanan I,Jain M,Ganti AK,Salgia R,Batra SK,Nasser MW

    更新日期:2020-11-18 00:00:00

  • Cell death in unusual but informative and beautiful model organisms.

    abstract::Cancer depends on cell death. It can emerge when cell death is deficient, and it could be treated through cancer-cell-specific induction of cell death. However, our understanding of cell death is still incomplete. While a few classical animal models have helped greatly in this respect, more may be learnt from non-clas...

    journal_title:Seminars in cancer biology

    pub_type: 社论

    doi:10.1016/j.semcancer.2006.11.001

    authors: Golstein P

    更新日期:2007-04-01 00:00:00

  • Environmental and chemical carcinogenesis.

    abstract::People are continuously exposed exogenously to varying amounts of chemicals that have been shown to have carcinogenic or mutagenic properties in experimental systems. Exposure can occur exogenously when these agents are present in food, air or water, and also endogenously when they are products of metabolism or pathop...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2004.06.010

    authors: Wogan GN,Hecht SS,Felton JS,Conney AH,Loeb LA

    更新日期:2004-12-01 00:00:00

  • APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

    abstract::The anaphase promoting complex/ cyclosome (APC/C), is an evolutionarily conserved protein complex essential for cellular division due to its role in regulating the mitotic transition from metaphase to anaphase. In this review, we highlight recent work that has shed light on our understanding of the role of APC/C coact...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.03.001

    authors: Schrock MS,Stromberg BR,Scarberry L,Summers MK

    更新日期:2020-12-01 00:00:00

  • Endogenous opiates, opioids, and immune function: evolutionary brokerage of defensive behaviors.

    abstract::Recent empirical data have elucidated a compelling physiological basis for endogenously expressed, chemically authentic, morphine and its cognate mu3 and mu4 opiate receptors. Cellular "morphinergic" signaling is predominantly targeted to autocrine/paracrine regulatory processes and is reciprocally linked to stimulate...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.12.001

    authors: Stefano GB,Kream R

    更新日期:2008-06-01 00:00:00

  • Proteomic research in sarcomas - current status and future opportunities.

    abstract::Sarcomas are a rare group of mesenchymal cancers comprising over 70 different histological subtypes. For the majority of these diseases, the molecular understanding of the basis of their initiation and progression remains unclear. As such, limited clinical progress in prognosis or therapeutic regimens have been made o...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.11.003

    authors: Burns J,Wilding CP,L Jones R,H Huang P

    更新日期:2020-04-01 00:00:00

  • Prostate-specific antigen.

    abstract::Prostate specific antigen (PSA) is serine protease produced at high concentrations by normal and malignant prostatic epithelium. It is mainly secreted into seminal fluid, where it digests the gel forming after ejaculation. Only minor amounts of PSA leak out into circulation from the normal prostate, but the release of...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1998.0086

    authors: Stenman UH,Leinonen J,Zhang WM,Finne P

    更新日期:1999-04-01 00:00:00

  • Extracellular RNA mediates and marks cancer progression.

    abstract::Different types of RNAs identified thus far represent a diverse group of macromolecules that are involved in the regulation of different biological processes. RNA is generally thought to be localized primarily in the nucleus and cytoplasm; however, some types of RNA have been detected in the extracellular milieu. Thes...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2014.04.010

    authors: Redzic JS,Balaj L,van der Vos KE,Breakefield XO

    更新日期:2014-10-01 00:00:00

  • Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy.

    abstract::Application of nanotechnologies to cancer therapy might increase solubility and/or bioavailability of bioactive compounds of natural or synthetic origin and offers other potential benefits in cancer therapy, including selective targeting. In the present review we aim to evaluate in vivo studies on the anticancer activ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.08.029

    authors: Aiello P,Consalvi S,Poce G,Raguzzini A,Toti E,Palmery M,Biava M,Bernardi M,Kamal MA,Perry G,Peluso I

    更新日期:2019-08-24 00:00:00

  • The potential and controversy of targeting STAT family members in cancer.

    abstract::The Signal Transducer and Activator of Transcription (STAT) family of proteins consists of transcription factors that play a complex and essential role in the regulation of physiologic cell processes, such as proliferation, differentiation, apoptosis and angiogenesis, and serves to organize the epigenetic landscape of...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.10.002

    authors: Verhoeven Y,Tilborghs S,Jacobs J,De Waele J,Quatannens D,Deben C,Prenen H,Pauwels P,Trinh XB,Wouters A,Smits ELJ,Lardon F,van Dam PA

    更新日期:2020-02-01 00:00:00

  • Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy.

    abstract::The need for more effective cancer therapies is omnipresent as the ever-complex, and highly adaptive, mechanisms of tumor biology allow this disease to elude even the most stringent treatment options. The expanding field of proteoglycan signaling is enticing as a reservoir of potential drug targets and prospects for n...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.05.003

    authors: Gubbiotti MA,Buraschi S,Kapoor A,Iozzo RV

    更新日期:2020-05-01 00:00:00

  • Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.

    abstract::Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Similar to many other malignancies, CRC is a heterogeneous disease, making it a clinical challenge for optimization of treatment modalities in reducing the morbidity and mortality associated with this disease. A more precise under...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.05.002

    authors: Wang W,Kandimalla R,Huang H,Zhu L,Li Y,Gao F,Goel A,Wang X

    更新日期:2019-04-01 00:00:00

  • Matrix Metalloproteinases: A challenging paradigm of cancer management.

    abstract::Matrix metalloproteinases (MMPs) are members of zinc-dependent endopeptidases implicated in a variety of physiological and pathological processes. Over the decades, MMPs have been studied for their role in cancer progression, migration, and metastasis. As a result, accumulated evidence of MMPs incriminating role has m...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.11.008

    authors: Alaseem A,Alhazzani K,Dondapati P,Alobid S,Bishayee A,Rathinavelu A

    更新日期:2019-06-01 00:00:00

  • Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.

    abstract::Growing evidence supports the notion that pharmaceutical targeting of the 5-hydroxytryptamine (5-HT) and dopamine (DA) systems offers the potential to treat human immune system disorders. This review describes this emerging area of research, which has the benefit of being supported by a relatively detailed understandi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.12.007

    authors: Barnes NM,Gordon J

    更新日期:2008-06-01 00:00:00

  • H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells.

    abstract::Histamine is produced from histidine by histidine decarboxylase (HDC) in many cells including normal and malignant lymphocytes. We examined the expression of HDC and the effect of histamine receptor antagonists on the proliferation of a human T cell line, Jurkat and on antigen-driven proliferation of lymphocytes from ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0306

    authors: Radvány Z,Darvas Z,Kerekes K,Prechl J,Szalai C,Pállinger E,Valéria L,Varga VL,Sandor M,Erdei A,Falus A

    更新日期:2000-02-01 00:00:00

  • Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer.

    abstract::Human gut microbiota is a dynamic and variable system that can change over time and in response to different diets and treatments. There is currently no doubt that gut microbiota can provide interesting therapeutic opportunities, since it can metabolize biologically active molecules, drugs, and their precursors, and c...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.06.017

    authors: Wu WK,Ivanova EA,Orekhov AN

    更新日期:2020-06-28 00:00:00

  • Fibronectin and cancer: rationales for the use of antiadhesives in cancer treatment.

    abstract::Alterations in the rate and pattern of cell movement are prominent features of many human diseases, including inflammation, cardiovascular disease and cancer. The ability to regulate the interactions of cells with each other and with adhesion factors in extracellular matrices therefore offers a novel approach to the t...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Humphries MJ

    更新日期:1993-10-01 00:00:00